45
Participants
Start Date
March 14, 2022
Primary Completion Date
February 27, 2024
Study Completion Date
February 27, 2024
ADP101
Active dry powder formulation at various volumes.
Study Site, Chapel Hill
Study Site, Charleston
Study Site, Marietta
Study Site, Atlanta
Study Site, Tampa
Study Site, Cincinnati
Study Site, Ann Arbor
Study Site, Normal
Study Site, Denver
Study Site, Colorado Springs
Study Site, Rolling Hills Estates
Study Site, San Diego
Study Site, Mission Viejo
Study Site, Seattle
Lead Sponsor
Alladapt Immunotherapeutics, Inc.
INDUSTRY